These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 28938409)
1. Letter to the Editor: "Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis". Azziz R J Clin Endocrinol Metab; 2017 Oct; 102(10):3865-3866. PubMed ID: 28938409 [No Abstract] [Full Text] [Related]
2. Proliferation and apoptosis in ovarian stromal hyperplasia and hyperthecosis. Sharabidze N; Sabakhtarashvili M; Burkadze G Georgian Med News; 2005 Dec; (129):26-9. PubMed ID: 16444023 [TBL] [Abstract][Full Text] [Related]
3. Cell adhesion and apoptosis in ovarian stromal hyperplasia and hyperthecosis. Sharabidze N; Burkadze G; Sabakhtarashvili M Georgian Med News; 2006 Feb; (131):33-7. PubMed ID: 16575127 [TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome. Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550 [TBL] [Abstract][Full Text] [Related]
9. WEEKLY clinicopathological exercise: ovarian hyperthecosis; reticular zone hyperplasia of adrenals. N Engl J Med; 1952 Apr; 246(17):667-70. PubMed ID: 14919901 [No Abstract] [Full Text] [Related]
10. Insulin resistance in a patient with ovarian stromal hyperthecosis and the hyperandrogenism, insulin resistance and acanthosis nigricans syndrome. Report of a case with a possible endogenous ovarian factor. Mantzoros CS; Lawrence WD; Levy J J Reprod Med; 1995 Jun; 40(6):491-4. PubMed ID: 7650669 [TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect. Barbieri RL; Hornstein MD Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472 [TBL] [Abstract][Full Text] [Related]
12. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563 [TBL] [Abstract][Full Text] [Related]
13. Ovarian pathology associated with insulin resistance and acanthosis nigricans. Annos T; Taymor ML Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247 [TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor from Chenyun Miao, et al: "Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome". Miao C; Fang X; Zhang Q J Clin Endocrinol Metab; 2021 Apr; 106(5):e2378-e2379. PubMed ID: 33524132 [No Abstract] [Full Text] [Related]
15. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841 [TBL] [Abstract][Full Text] [Related]
16. OVARIAN HYPERTHECOSIS AND VIRILIZATION: REPORT OF A CASE. TRAVIS R; AARON JB; STONE B Obstet Gynecol; 1965 Jun; 25():797-801. PubMed ID: 14287470 [No Abstract] [Full Text] [Related]
17. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis. Brown RJ; Joseph J; Cochran E; Gewert C; Semple R; Gorden P J Clin Endocrinol Metab; 2017 Jun; 102(6):1789-1791. PubMed ID: 27911591 [TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome". Livadas S J Clin Endocrinol Metab; 2018 Jan; 103(1):360-361. PubMed ID: 29126227 [No Abstract] [Full Text] [Related]
20. Response to Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome". Glintborg D; Rubin KH; Abrahamsen B; Andersen M J Clin Endocrinol Metab; 2018 Jan; 103(1):362-363. PubMed ID: 29126200 [No Abstract] [Full Text] [Related] [Next] [New Search]